Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!

Why Nestle lost $2.1 billion on this peanut allergy cure

Mar 21, 2023
The Swiss grocery giant bought the maker of Palforzia as part of an effort to take Nestle into the profitable health and wellness space.
Nestle CEO Mark Schneider bought the maker of Palforzia, a peanut allergy cure, as part of a pivot toward the intersection of nutrition and pharmaceuticals.
Fabrice Coffrini/Getty Images

Will allergies doom the peanut industry?

Oct 15, 2013
Northwestern will hold its first peanut-free football game – in deference to those with peanut allergies.
Northwestern's Ryan Field.
Flickr/Sergio Goncalves